Building Global Consensus for Liquid Biopsies to Drive Universal Clinical Integration of Liquid Biopsy
- Building alignment across stakeholders on assay performance and interpretation, including diagnostic vendors, biopharma, consortia and others
- Reducing variability through shared standards and best practices, including standardizing parameters
- Enabling broader clinical integration through harmonized approaches